Serum ferritin and transferrin saturation levels in β0 and β + thalassemia patients

There have been few studies on the mutations that cause heterozygous beta-thalassemia and how they affect the iron profile. One hundred and thirty-eight individuals were analyzed, 90 thalasemic β0 and 48 thalasemic β+, identified by classical and molecular methods. Mutations in the hemochromatosis (...

Descripción completa

Detalles Bibliográficos
Autores: Estevão, I. F. [UNESP], Peitl, Jr. [UNESP], Bonini-Domingos, C. R. [UNESP]
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2011
País:Brasil
Institución:Universidade Estadual Paulista (UNESP)
Repositorio:Repositório Institucional da UNESP
Idioma:inglés
OAI Identifier:oai:repositorio.unesp.br:11449/72427
Acceso en línea:http://dx.doi.org/10.4238/vol10-2gmr1016
http://hdl.handle.net/11449/72427
Access Level:acceso abierto
Palabra clave:Beta-thalassemia
Ferritin
Hyperferritinemia
Transferrin saturation
beta globin
ferritin
hemojuvelin
transferrin
adult
age
aged
beta thalassemia
clinical feature
controlled study
female
ferritin blood level
gene mutation
hemochromatosis
heterozygosity
high performance liquid chromatography
human
iron metabolism
major clinical study
male
mutational analysis
polymerase chain reaction
sex difference
single nucleotide polymorphism
transferrin blood level
Adult
Age Factors
Aged
Aged, 80 and over
beta-Thalassemia
Female
Ferritins
Hemochromatosis
Heterozygote
Humans
Iron
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Sex Factors
Transferrin
Descripción
Sumario:There have been few studies on the mutations that cause heterozygous beta-thalassemia and how they affect the iron profile. One hundred and thirty-eight individuals were analyzed, 90 thalasemic β0 and 48 thalasemic β+, identified by classical and molecular methods. Mutations in the hemochromatosis (HFE) gene, detected using PCR-RFLP, were found in 30.4% of these beta-thalassemic patients; heterozygosity for H63D (20.3%) was the most frequent. Ferritin levels and transferrin saturation were similar in beta-thalassemics with and without mutations in the HFE gene. Ferritin concentrations were significantly higher in men and in individuals over 40 years of age. Transferrin saturation also was significantly higher in men, but only in those without HFE gene mutations. There was no significant difference in the iron profile among the β0 and β+ thalassemics, with and without HFE gene mutations. The frequency of ferritin values above 200 ng/mL in women and 300 ng/mL in men was also similar in β0 and β+ thalassemics (P > 0.72). Our conclusion is that ferritin levels are variable in the beta-thalassemia, trait regardless of the type of beta-globin mutation. Furthermore, HFE gene polymorphisms do not change the iron profile in these individuals. ©FUNPEC-RP www.funpecrp.com.br.